期刊文献+

筛查发现的小体积非小细胞肺癌治疗相关的问题探讨——术中定位、切除范围、淋巴结清扫 被引量:1

Issues Relevant to Surgical Intervention in 'Tiny' Non-small Cell Lung Cancer Detected by 'Lung Screening'--Orientation, Lung Resection and Lymph Node Resection
下载PDF
导出
摘要 随着胸部计算机断层扫描(computed tomography,CT)的广泛应用,以及肺癌高危人群筛查的逐渐开展,越来越多的"小肺癌"被发现及诊断。"小肺癌"具有的术中定位困难、侵袭性弱、近期和远期预后较好的特点为肺癌的外科治疗提出了新的挑战,本文着重从肺癌的筛查、小结节定位、肺叶切除与亚肺叶切除以及淋巴结清扫范围等方面对"小肺癌"带来的挑战进行探讨。 With the widely application of chest computed tomography(CT) and gradual generalization of lung cancer screening project for high risk populations, more and more "tiny lung cancers" were identified. Due to the difficulty in intraoperative orientation, their less aggressiveness, and excellent short/long term prognosis, the ‘tiny lung cancers' posed new challenges for the surgery in the treatment of lung cancer. In this review, theirfore, we focused on these challenges and presented the progress in lung cancer screening, orientation of lung nodules, lobectomy and sublobectomy, and lymph node dissection.
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2016年第6期347-350,共4页 Chinese Journal of Lung Cancer
基金 国家临床重点专科建设项目(No.[2011]873)资助~~
关键词 肺肿瘤 筛查 肺叶切除 亚肺叶切除 淋巴结清扫 Lung neoplasms Lung screening Lobectomy Sublobectomy Lymph node resection
  • 相关文献

参考文献20

  • 1Siegel K, Ma J, Zou z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
  • 2Bender E. Epidemiology: The dominant malignancy. Nature, 2014, 513(7517): $2-$3.
  • 3Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
  • 4Henschke CI, Yankelevitz DF, Smith JP, et al. ELCAP Group. Screening for lung cancer: the early lung cancer action approach. Lung Cancer, 2002, 35(2): 143-148.
  • 5International Early Lung Cancer Action Program Investigators, Henschke CI,Yankelevitz DF, et al. Survival of patients with stage lung cancer detected on CT screening. N EnglJ Med, 2006, 355(17): 1763-1771.
  • 6National Lung Screening Trial Research Team, Abede DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N EnglJ Med, 2011, 365(5): 395-409.
  • 7Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for TIN0 non-smaU cell lung cancer. Lung Cancer Study Group. Ann Tnorac Surg0 1995, 60(3): 615-623.
  • 8Yendamuri S, Sharma R, Demmy M, et al. Temporal trends in outcomes following sublobar and lobar resections for small (2 cm) non-small cell tung cancers-a Surveillance Epidemiology End Results database analysis. J Surg Res, 2013, 183(1): 27-32.
  • 9Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol, 2010, 40(3): 271-274,.
  • 10National Institutes of Health. Phase III Randomized Study of Lobectomy Versus Sublobar Resection in Patients With Small Peripheral Stage IA Non-Small Cell Lung Cancer. http://www.cancer.gov/clinicahrials/ CALGB- 140503.

同被引文献44

  • 1Taylor C, Munro A J, Glynne-Jones R, et al. Muhidisciplinary team working in cancer:what is the evidence[ J]. BMJ(Clinical research ed. ) ,2010,340 : c951.
  • 2Boxer MM,Vinod SK, Shafiq J,et al. Do multidisciplinary team meet- ings make a difference in the management of lung cancer[J]. Cancer, 2011,117(22) :5112-5120.
  • 3Ost DE, Yeung SC, Tanoue LT, et al. Clinical and organizational fac- tors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer,3rd ed:American College of Chest Physi- cians evidence-based clinical practice guidelines [ J ]. Chest,2013,143 (5 Suppl) :e121S-141S.
  • 4Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. 2014.
  • 5Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project : Proposalsfor the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer[ J ]. Journal of thoracic oneol- ogy :official publication of the International Association for the Study of Lung Cancer,2015,10(12) :1675-1684.
  • 6Eguehi T, Kadota K, Park B J, et al. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know [ J ]. Seminars in thoracic and cardiovascular surgery, 2014,26 ( 3 ) :210- 222.
  • 7Travis WD, Brambilla E, Burke AP, et al. WHO Classification of tumours of the lung, pleura, thymus and heart. 4th edition [ J ]. Lyon : International Agency for Research on Cancer,2015.9-96.
  • 8Santos ES, Castrellon AB, Blaya M, et al. Controversies in the manage- ment of stage IRA non-small-cell lung cancer [ J ]. Expert Review of Anticancer Therapy,2014,8 (12) : 1913.
  • 9Mery B, Guy JB, Swalduz A, et al. The evolving locally-advanced non- small cell lung cancer landscape : Building on past evidence and expe- rience[ J ]. Critical reviews in ontology/hematology, 2015,96 ( 2 ) : 319-327.
  • 10Group NM-aC. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual partici- pant data[ J ]. Lancet,2014,383 (9928) : 1561-1571.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部